New monoclonal antibody antivenoms that cause fewer allergic reactions are being developed. Like Mulford’s initial 1927 antivenom product, CroFab antivenom is an antidote to the venom of North ...

Anavip entered the market in 2018 as the only competitor to the antivenom CroFab. But its makers settled a patent ...

Another explanation for antivenom's high cost is a lack of meaningful competition. Anavip entered the market in 2018 as the only competitor to CroFab. But its makers settled a patent infringement ...